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Abstract 
Background: Malaria in pregnancy is a critical public health challenge, and intermittent preventive treatment for 
malaria during pregnancy (IPTp) has proven to be an effective intervention. However, access to and use of malaria 
interventions, including IPTp, remains a considerable problem among African women. This cross‑sectional study 
investigated factors, including antenatal care (ANC) attendance (both numbers of visits and timing of the first visit) 
and socio‑demographics, associated with the uptake of the recommended IPTp dose among Malawian women.
Methods: A nationally representative sample of women with a live birth in the 2 years preceding the survey from 
the Malawi Demographic Health Survey 2015–2016 dataset was analysed. Self‑reported data on socio‑demographics, 
ANC attendance and IPTp uptake were collected using a questionnaire and analysed using logistic models.
Results: Of the 6549 included women, 1981 (30.2%) took the recommended three or more IPTp doses. Despite inad‑
equate ANC visits, early ANC initiation increased the likelihood of these women taking the recommended IPTp dose; 
women who initiated ANC in the first [adjusted odds ratio (aOR) = 2.24; 95% confidence interval (CI) = 1.44–3.49] and 
second (aOR = 2.19; 95% CI = 1.56–3.08) trimesters were more likely to take the recommended IPTp dose compared 
to late initiators. The effect of the number of ANC visits on IPTp uptake was significant in married women (aOR = 1.68, 
95% CI = 1.42–1.98), and the timing of first ANC visit was associated with IPTp uptake only among rural women 
(aOR = 2.13, 95% CI = 1.54–2.95).
Conclusion: ANC attendance is vital in IPTp uptake. The results highlight the need for health care providers to 
encourage women, particularly those in high‑risk groups, to make frequent ANC visits and receive early ANC initiation 
to ensure high coverage of the recommended IPTp dose.
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Background
Malaria remains a critical public health issue, with par-
ticular burden of disease on children aged younger than 
5  years and pregnant women [1]. Malaria in pregnancy 
(MIP) poses a serious threat to mothers, fetuses and 
newborns, leading to infant and maternal mortality, low 
birth weight, and maternal anaemia [1]. Globally, MIP is 
responsible for 10,000 maternal deaths per year [2]. Fur-
thermore, in sub-Saharan Africa, it accounts for 20 and 
11% of stillborn and neonatal deaths, respectively [3, 4].
Malawi is a malaria-endemic country. Between 2009 
and 2014, an infection rate of 19.6% was reported among 
pregnant women attending their first antenatal care 
(ANC) service in a peri-urban area of Ndirande, in Blan-
tyre [5]. In addition to the aforementioned impact of MIP, 
the economic burden of malaria in Malawi is high. An 
average Malawian family spends approximately US$17.48 
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per malaria episode, which is higher than a week’s 
income for most Malawian families [6]. Considering the 
adverse effects of MIP, the use of intermittent preven-
tive treatment for malaria during pregnancy (IPTp) is one 
of the most important strategies adopted by the Malawi 
Ministry of Health (MoH) to reduce the MIP burden [7].
In IPTp, pregnant women are prescribed sulfadoxine–
pyrimethamine (SP) [8]. The World Health Organization 
(WHO) recommends that women in malaria-endemic 
areas should be given the IPTp dose during ANC visits 
as early as possible in the second trimester and that sub-
sequent doses should be given at 4-week intervals [9]. 
An appropriate dose of IPTp reduces maternal mortality 
along with the risks of maternal anaemia and low birth 
weight [10]. A Malawian study, conducted in Blantyre 
from July 1997 to April 1999, reported a significant asso-
ciation between SP use and reduced placental malaria 
parasite prevalence among IPTp non-users (31.9%) and 
users (22.8%) [11].
In 1993, Malawi became the first country worldwide 
to implement an IPTp policy, recommending two doses 
of SP to all pregnant women [12–14], 5 years before the 
WHO released its IPTp recommendations [15]. There-
after, the coverage with two doses of IPTp (formerly, the 
recommended dose) has been relatively high in Malawi 
compared to the rest of sub-Saharan Africa [16–18]. 
In 2015, 63% of pregnant women received at least two 
doses; the percentage of women receiving one IPTp dose 
increased from 80.7% in 2006 to 89% in 2015 [19, 20]. In 
Malawi, monitoring of the uptake of 3 IPTp doses started 
in 2014, after IPTp policy was updated by the WHO in 
2012 [9, 19]; however, the uptake of 3 doses was as low as 
12% in 2014. Although the 3-dose recommendation was 
new in 2014 and despite it being a regional leader in IPTp 
uptake, Malawi still failed to meet its own 2011–2015 
Malaria Strategic Plan target of having 80% coverage of 
the uptake of 2 IPTp doses among pregnant women [18, 
19, 21]. Nevertheless, increasing its uptake is crucial to 
reducing MIP burden. The effects of socio-demographics 
(e.g., education and parity) on IPTp uptake have been 
well documented [22–27]. For instance, a 2009 study con-
ducted in 8 Malawian districts revealed that women who 
had secondary- or tertiary-level education were more 
likely to take the recommended number of IPTp doses 
than those without formal education [24]. However, stud-
ies have also reported contrasting findings regarding the 
influence of socio-demographics on IPTp uptake [22–25, 
27]. Although a Tanzanian study found parity to be a 
crucial predictor of IPTp uptake [23], no association was 
reported in western Nigeria [28].
Although several studies have examined the effects 
of ANC attendance on IPTp uptake, the association has 
been inconsistent [26, 29–33]. For example, a Kenyan 
study found an association between the timing of first 
ANC visit and uptake of IPTp [29], whereas studies in 
Uganda, Tanzania, and Nigeria have reported no such 
association [34–37]. In Cameroon, less frequent clinic 
visits during pregnancy prevented the uptake of the rec-
ommended IPTp dose [38], whereas no such association 
was observed in Kenya [29]. The observed differences 
might be due to the various assessment durations; the 
Kenyan study [29] included not only currently pregnant 
women but also mothers with children aged under 1 year, 
whereas the Cameroonian study [38] was restricted to 
pregnant women. In addition, this inconsistency might 
be explained by the lack of consideration of the poten-
tial interactive effects of socio-demographics and ANC 
attendance on IPTp uptake.
Understanding the factors affecting IPTp uptake is crit-
ical for promoting and designing targeted interventions 
to improve the coverage of IPTp. Studies on the influ-
ence of both ANC attendance and socio-demographics 
on IPTp have focused only on their independent effects; 
thus far, limited empirical evidence is available on their 
interactive effects. Examining the effect modifiers of the 
relationship between ANC attendance and IPTp uptake is 
critical for identifying groups with a high risk of low IPTp 
uptake. Furthermore, although both the number of ANC 
visits and timing of first ANC visit are prominent factors, 
studies on ANC attendance and IPTp uptake have not 
elucidated how these two factors (i.e., number and tim-
ing) independently affect IPTp uptake, considering that 
the timing of first ANC visit may also influence the num-
ber of ANC visits, as reported in Tanzania [39].
Therefore, this study examined the relationship 
between ANC attendance, socio-demographics, and 
IPTp uptake among Malawian women by using a nation-
ally representative sample. In particular, the study aimed 
to: (1) examine the factors (i.e., ANC attendance and 
socio-demographics) associated with the uptake of the 
recommended IPTp dose; (2) evaluate the independent 
association between the number of ANC visits and tim-
ing of first ANC visit on IPTp uptake; and, (3) investigate 
the moderating effects of socio-demographics on the 
relationship between ANC attendance and IPTp uptake.
Methods
Study design and data source
This cross-sectional study utilized data from the 2015 to 
2016 Malawi Demographic and Health Survey (MDHS) 
[40]. The study design, methodology and sampling 
method have been described elsewhere in detail [40]. 
In summary, the sampling frame was the 2008 Malawi 
Population and Housing Census [40]. A two-stage strati-
fied sampling method was used. The first stage involved 
the selection of standard enumeration areas (SEAs) from 
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among 850 SEAs of Malawi. The second stage involved 
equal probability systematic selection of households in 
each SEA. Women aged 15–49  years who were either 
permanent residents of the selected households or visi-
tors who stayed in the household the night before the 
survey were eligible to be interviewed. Data were col-
lected from 9 October, 2015 to 17 February, 2016. The 
questionnaire was translated into Chichewa and Tum-
buka (prominent local languages). Pre-testing was con-
ducted in July and August 2015. All data collectors were 
trained and had experience with household surveys. Of 
25,146 eligible women, 24,562 were successfully inter-
viewed, indicating a 98% response rate.
To reduce recall bias and in line with the Roll Back 
Malaria Indicator on IPTp, the sample was restricted to 
women who had had a live birth in the 2  years preced-
ing the survey [27, 41]. In total, 6549 women were finally 
included.
Outcome variable
As per WHO recommendations, the outcome measure 
was defined as the uptake of fewer than 3 IPTp doses (low 
uptake) or the uptake of 3 or more IPTp doses (recom-
mended dose) [9].
Independent variables
ANC attendance, the main independent predictor for 
IPTp uptake in this study, was assessed using two items, 
namely ‘number of ANC visits’ and ‘timing of first ANC 
visit’ [25, 38]. The number of ANC visits was categorized 
into two levels: adequate (4 or more) and inadequate 
(fewer than 4), according to WHO recommendations [9, 
42]. The timing of first ANC visit was categorized accord-
ing to the first, second, and third trimester.
Socio-demographics were also examined for their 
effects on IPTp uptake. In particular, three-level vari-
ables were used to categorize age (15–24, 25–34 and 
≥ 35  years), education (no formal education, primary 
education, secondary and above), marital status (mar-
ried, never married, separated, widowed or divorced), 
and parity (primigravida, secundigravida, multigravida). 
Marital status was further assessed as a binary variable 
(married vs unmarried) in sub-group analysis. Principal 
component analysis was applied to the MDHS data for 
calculating wealth on the basis of household assets, such 
as bicycles and mobile phones. The calculated wealth was 
then categorized into quintiles, with the lowest to highest 
indicating the poorest to richest. In this study, wealth was 
categorized into a three-level variable by combining two 
sub-categories into single categories: poorest and poor 
into poor and rich and richest into rich, with the middle 
category unchanged.
Statistical analyses
The distribution of participants according to the number 
of ANC visits was analysed using the Chi square test. The 
distributions of ANC attendance and socio-demograph-
ics by IPTp uptake, along with their effects on the uptake, 
were further examined.
To investigate the association between the number of 
ANC visits and timing of first ANC visit on IPTp uptake, 
a single variable, ANC use, was generated and coded into 
the following 6 groups: (1) inadequate ANC visits and 
first ANC visit in first trimester; (2) inadequate ANC vis-
its and first ANC visit in second trimester; (3) inadequate 
ANC visits and first ANC visit in third trimester; (4) 
adequate ANC visits and first ANC visit in first trimes-
ter; (5) adequate ANC visits and first ANC visit in second 
trimester; and, (6) adequate ANC visits and first ANC 
visit in third trimester. Group 3 (inferior situation) was 
used as the reference group, against which women from 
the other categories were compared. Logistic regression 
analyses were performed to estimate ORs and their 95% 
CIs for the association between ANC use and recom-
mended IPTp uptake.
Interactions of ANC attendance (i.e., number of ANC 
visits and timing of first ANC visit) and socio-demo-
graphics with IPTp uptake were examined. A p of < 0.1 
was used for interaction terms to signal potential mod-
eration [43], and a sub-group analysis was further used to 
examine the moderation effects.
All analyses considered the complex sample design, 
and only weighted data were used for analysis. Sample 
weighting allowed for adjustments to the cluster sam-
pling design and sampling probabilities across clusters 
and strata. The level of significance was set at p < 0.05 
(two-tailed), and all analyses were performed using SPSS 
software version 22.0 (SPSS, Chicago, IL, USA).
Ethical considerations
Informed consent for the survey was obtained from each 
respondent at the start of each individual interview. Ethi-
cal approval was obtained from the Malawi National 
Health Sciences Research Committee of the Malawi Min-
istry of Health prior to the survey. The MDHS data sets 
are publicly available, and clearance to analyse them was 
provided by the International Classification of Function-
ing Disability and Health (ICF) under the Demographic 
Health Survey (DHS) programme.
Results
Distribution of participants by number of ANC visits
In total, 6549 women with a live birth in the 2 years prior 
to the survey participated in this study. Of them, 48.1% 
had adequate ANC visits. Table  1 displays the distribu-
tion of participants according to their number of ANC 
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visits. The difference between women with adequate 
ANC visits and with inadequate ANC visits was signifi-
cant (p < 0.05), in terms of age, marital status, education, 
occupation, wealth, residence, IPTp uptake, and timing of 
first ANC visit, but not parity and region.
Distribution of participants by IPTp uptake and potential 
predictors recommended IPTp uptake
Approximately 30.2% of the included women received 
the recommended IPTp dose. Distributions of potential 
predictors of IPTp uptake are listed in Table  2. Signifi-
cant differences were observed between those with and 
without recommended IPTp uptake (p < 0.05), in terms of 
region, number of ANC visits, and timing of first ANC 
visit, but not the remaining variables. In the crude logis-
tic regression analysis, age of ≤ 24 years (OR = 1.25, 95% 
CI = 1.03–1.51), adequate ANC visits (OR = 1.68, 95% 
CI = 1.47–1.92), and first ANC visit in first (OR = 2.72, 
95% CI = 1.97–3.76) and second (OR = 2.30, 95% 
CI = 1.69–3.12) trimesters were significantly associated 
with increased odds of taking the recommended IPTp 
dose (p < 0.05).
IPTp uptake stratified by number of ANC visits and timing 
of first ANC visit
Table 3 presents the odds of recommended IPTp uptake 
stratified by the number of ANC visits and timing of 
first ANC visit. After adjustment for age, parity, mari-
tal status, education, wealth, and occupation, women 
who had reported for the first ANC visit in their first 
and second trimesters were more likely to take the rec-
ommended IPTp dose (aOR = 1.97, 95% CI = 1.40–2.76 
and aOR = 1.93, 95% CI = 1.42–2.64, respectively) than 
women who reported in their third trimester. Similarly, 
women with adequate ANC visits were more likely to 
take the recommended dose than those with inadequate 
ANC visits (aOR = 1.55, 95% CI = 1.34–1.80).
Further examination of the association between the 
number of ANC visits and timing of first ANC visit (i.e., 
ANC use in the 6 groups) revealed that women with ade-
quate ANC visits who had reported for their first ANC 
visit in the first or second trimester were approximately 
3 times more likely to take the recommended IPTp dose 
(aOR = 3.41, 95% CI = 2.39–4.86 and aOR = 3.33, 95% 
CI = 2.36–4.70, respectively), than women who had inad-
equate ANC visits and had reported for their first ANC 
visit in the third trimester. Moreover, women with ade-
quate ANC visits who reported for their first ANC visit 
in the third trimester were approximately 5 times more 
likely to take the recommended IPTp dose (aOR = 4.74, 
95% CI = 1.61–13.96) than women in the reference 
group.
Notably, among women with inadequate ANC visits, 
those who had reported for their first ANC visit in the 
first and second trimesters were approximately 2 times 
more likely to take the recommended dose (OR = 2.24, 
95% CI = 1.44–3.49 and OR = 2.19, 95% CI = 1.56–3.08, 
respectively) than reference group women.
The design of the MDHS survey incorporates both resi-
dents of the selected households and visitors. Thus, in the 
sample, only 58 women (0.9%) with a live birth 2  years 
before the survey were visitors. A sensitivity analysis to 
include only resident women for examination was further 
conducted and the results were consistent. Therefore, the 
findings from the whole sample were reported to comply 
with the MDHS survey design.
Sub‑group analysis for effects of socio‑demographics 
on ANC attendance and recommended IPTp uptake
The interaction terms (i.e., number of ANC visits and 
socio-demographics (i.e., residence, education, wealth, 
age, parity, and marital status)) on IPTp uptake (p < 0.1) 
were considered in sub-group analysis. In the sub-
group analysis, the effect of the number of ANC visits 
on IPTp uptake was significant in the poor and middle 
wealth groups (aOR = 1.94, 95% CI = 1.39–2.71 and 
aOR = 1.75, 95% CI = 1.45–2.11, respectively), 25–34 and 
15–24 years old women (aOR = 2.02, 95% CI = 1.59–2.06 
and aOR = 1.48, 95% CI = 1.19–1.83, respectively), all lev-
els of parity with higher odds for the multigravida group 
(aOR = 1.74, 95% CI = 1.42–2.13), and married women 
(OR = 1.68, 95% CI = 1.42–1.98; Fig. 1). Furthermore, to 
examine ANC timing, reporting for the first ANC visit in 
the first and second trimesters (desirable ANC timing) 
was compared with reporting for the first ANC visit in 
the third trimester (undesirable ANC timing). The inter-
action between ANC timing and residence was signifi-
cant (p = 0.014). The association between desirable ANC 
timing on IPTp uptake was significant only among rural 
residents (aOR = 2.13, 95% CI = 1.54–2.95; Fig. 2).
Discussion
According to literature, this is the first study attempt-
ing to identify the association between timing of the 
first ANC visit and number of ANC visits, and also to 
evaluate the interactive effects of ANC attendance and 
socio-demographics on IPTp uptake. Having more ANC 
visits was expected to increase the likelihood of tak-
ing the recommended IPTp dose. However, the study 
revealed that although inadequate ANC visits (< 4) were 
noted, women who had their first ANC visit earlier in 
the first and second trimesters respectively had 2.24- and 
2.19-fold increased odds of receiving the recommended 
IPTp dose. The effects of adequate ANC visits on taking 
the recommended IPTp dose were significant in married 
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women, those aged ≤ 34  years, and those in the middle 
or poor wealth categories, whereas early ANC initiation 
was associated with an increased likelihood of taking the 
recommended IPTp dose among rural women only.
The rate of recommended IPTp uptake was 30.2%. A 
substantially lower rate (11%) was reported in Simuyu, 
Tanzania [44]. The change in the WHO IPTp policy in 
2014 (minimum number of doses from 2 to 3) may have 
Table 1 Distribution of participants according to number of ANC visits
ANC antenatal care, IPTp intermittent preventive treatment for malaria during pregnancy
* p < 0.05; ** p < 0.01; *** p < 0.001
a The number of ANC visits was categorized into two levels: adequate ANC visits (4 or more) and inadequate ANC visits (fewer than 4)
b p value of Pearson’s Chi squared test
Variable Total (n = 6549) Number of ANC visit categories p  valueb
Inadequatea (n = 3402) Adequatea (n = 3147)
n n (%) n (%)
Age (years) 0.035*
 15–24 3043 1642 (48.3) 1401 (44.5)
 25–34 2517 1246 (36.6) 1271 (40.4)
 ≥ 35 989 514 (15.1) 475 (15.1)
Marital status 0.012*
 Married 5470 2799 (82.3) 2671 (84.9)
 Never married 346 210 (6.2) 136 (4.3)
 Separated/divorced/widowed 733 393 (11.6) 340 (10.8)
Education < 0.001***
 No formal education 785 444 (13.0) 341 (10.8)
 Primary 4382 2350 (69.1) 2032 (64.6)
Secondary and above 1382 608 (17.9) 774 (24.6)
Occupation 0.049*
 Unemployed 2086 1130 (33.2) 956 (30.4)
 Employed 4463 2272 (66.8) 2191 (69.6)
Parity 0.132
 Primigravida 1818 899 (26.4) 919 (29.2)
 Secundigravida 1352 722 (21.2) 630 (20.0)
 Multigravida 3379 1781 (52.4) 1598 (50.8)
Wealth index < 0.001***
 Poor 3147 1724 (50.7) 1423 (45.2)
 Middle 1261 690 (20.3) 571 (18.2)
 Rich 2141 988 (29.0) 1153 (36.6)
Residence < 0.001***
 Urban 897 381 (11.2) 516 (16.4)
 Rural 5652 3021 (88.8) 2631 (83.6)
Region 0.841
 Northern 748 389 (11.4) 359 (11.4)
 Central 2756 1418 (41.7) 1338 (42.5)
 Southern 3045 1595 (46.9) 1450 (46.1)
IPTp uptake < 0.001***
 < 3 4568 2551 (75.0) 2017 (64.1)
 ≥ 3 1981 850 (25.0) 1131 (35.9)
Timing of first ANC visit (n = 6413) < 0.001***
 First trimester 1503 325 (9.9) 1178 (37.5)
 Second trimester 4427 2492 (76.2) 1935 (61.6)
 Third trimester 483 452 (13.8) 31 (1.0)
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been partially responsible for this low uptake because 
most countries were still in the process of adopting 
the new guidelines. In the current study, only 48.1% 
of women had adequate ANC visits, similar to the 46% 
reported in an earlier Malawian study [45]. These results 
suggest that IPTp coverage and ANC attendance remain 
a challenge. The results increase the understanding of the 
factors affecting the uptake of such services, particularly 
emphasizing the associated effects of ANC attendance; 
further relevant research is warranted.
This study determined that women with adequate 
ANC visits were more likely to take the recommended 
IPTp dose, consistent with studies conducted in Cam-
eroon and Ghana [31, 33]. This may be because IPTp 
Table 2 Distribution of participants by uptake of IPTp and potential factors affecting uptake
ANC antenatal care, IPTp intermittent preventive treatment for malaria during pregnancy, CI confidence interval, OR odds ratio
* p < 0.05; ** p < 0.01; *** p < 0.001
a p value of Pearson’s Chi squared test
Variable < 3 doses (n = 4568) ≥ 3 doses (n = 1981) p  valuea OR (95% CI)
n (%) n (%)
Age (years) 0.055
 15–24 2070 (45.3) 973 (49.1) 1.25 1.03–1.51*
 25–34 1780 (39.0) 737 (37.2) 1.09 0.89–1.35
 ≥ 35 718 (15.7) 271 (13.7) 1.00
Marital status 0.505
 Never married 253 (5.5) 92 (4.7) 0.84 0.62–1.13
 Separated/divorced/widowed 509 (11.1) 225 (11.3) 1.01 0.82–1.25
 Married 3806 (83.3) 1664 (84.0) 1.00
Education 0.790
 No formal education 538 (11.8) 247 (12.5) 1.06 0.82–1.35
 Primary 3067 (67.1) 1314 (66.3) 0.98 0.82–1.18
 Secondary and above 963 (21.1) 420 (21.2) 1.00
Occupation 0.313
 Employed 3135 (68.6) 1329 (67.1) 0.93 0.81–1.07
 Unemployed 1433 (31.4) 652 (32.9) 1.00
Parity 0.373
 Primigravida 1242 (27.2) 575 (29.0) 1.12 0.95–1.32
 Secundigravida 936 (20.5) 417 (21.0) 1.08 0.89–1.29
 Multigravida 2390 (52.3) 989 (49.9) 1.00
Wealth index 0.886
 Rich 1484 (32.5) 656 (33.1) 0.98 0.84–1.15
 Middle 888 (19.4) 374 (18.9) 0.95 0.79–1.16
 Poor 2196 (48.0) 951 (48.0) 1.00
Residence 0.251
 Urban 649 (14.2) 248 (12.5) 0.87 0.68–1.11
 Rural 3919 (85.8) 1733 (87.5) 1.00
Region 0.044*
 Northern 550 (12.0) 198 (10.0) 0.86 0.70–1.06
 Central 1872 (41.0) 884 (44.6) 1.13 0.97–1.32
 Southern 2146 (47.0) 899 (45.4) 1.00
ANC visits < 0.001***
 Adequate (≥ 4) 2017 (44.2) 1131 (57.1) 1.68 1.47–1.92***
 Inadequate (< 4) 2551 (55.8) 850 (42.9) 1.00
First ANC visit timing (n = 6413) < 0.001***
 First trimester 985 (22.1) 518 (26.4) 2.72 1.97–3.76***
 Second trimester 3065 (68.8) 1362 (69.6) 2.30 1.69–3.12***
 Third trimester 405 (9.1) 78 (4.0) 1.00
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policies in these countries recommend that IPTp 
should be administered at ANC visits, preferably as 
direct observation therapy (DOT). Consequently, 
women with higher numbers of ANC visits are more 
likely to complete the required IPTp doses. By contrast, 
the Kenyan study found no such association [29]. Other 
factors, such as availability of drugs at ANC clinics and 
effective DOT implementation, might also contribute 
Table 3 Association between the number of ANC visits and IPTp uptake stratified by ANC timing
ANC  antenatal care, IPTp intermittent preventive treatment for malaria during pregnancy, CI confidence interval, OR odds ratio
* p < 0.05; ** p < 0.01; *** p < 0.001
a Adjusted for age, parity, marital status, education, wealth, and occupation
b The number of ANC visits was categorized into two levels: adequate ANC visits (four or more) and inadequate ANC visits (fewer than four)
Timing of the first ANC visit Number of ANC visit categories  ORa (95% CI) Total
Inadequateb Adequateb
First trimester 2.24 (1.44–3.49***) 3.41 (2.39–4.86***) 1.97 (1.40–2.76***)
Second trimester 2.19 (1.56–3.08***) 3.33 (2.36–4.70***) 1.93 (1.42–2.64***)
Third trimester 1.00 4.74 (1.61–13.96**) 1.00
Total 1.00 1.55 (1.34–1.80***)
Fig. 1 Sub‑group analysis for effects of socio‑demographics and number of ANC visits on recommended IPTp uptake. *p <0.05. The number of ANC 
visits was categorized into two levels: adequate ANC visits (4 or more) and inadequate ANC visits (fewer than 4) as reference. Results were adjusted 
for socio‑demographic variables (i.e., age, parity, marital status, education, wealth, occupation, and timing of the first ANC visit, excluding the 
variable treated as the effect modifier)
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to the observed differences [37, 46]. Additional stud-
ies are required to understand the health facility-based 
factors that could influence IPTp uptake, such as acces-
sibility of drugs at clinics and availability of clean water 
for DOT.
The current study’s results support the findings 
observed in Tanzania and Ghana [23, 33], where women 
with ANC initiation in the first and second trimesters 
reported a higher IPTp uptake. However, other authors 
[34–37, 47] have reported no such association, poten-
tially because of the different designs employed in these 
studies; for instance, Kibusi et al. [23] conducted a quan-
titative study, whereas Rass et al. [37] conducted a quali-
tative study. If a woman reports for ANC in the third 
trimester, she may not receive the full IPTp dose because 
of the delay in initiation of IPTp uptake.
Compared with other studies [23, 25, 26, 33, 38], this 
study further demonstrated the independent association 
between timing of the first ANC visit, in addition to the 
number of ANC visits, and IPTp uptake among pregnant 
women. In particular, the results suggest that reporting 
for the first ANC earlier during pregnancy, despite hav-
ing an inadequate number of ANC visits, was associated 
with recommended IPTp uptake. ANC clinics are the 
main sources of disseminating crucial health informa-
tion to women during pregnancy. Therefore, women may 
be advised on the importance of IPTp when they visit 
the ANC clinic early, and therefore, they may be able to 
source the drug from elsewhere if they fail to attend sub-
sequent ANC visits [48].
Increased odds of recommended IPTp uptake in those 
with adequate visits despite having late initiation of ANC 
were also observed, but with a wider confidence interval, 
possibly because of the smaller sample number in this 
category. Two Ghanaian studies reported that 4 or more 
ANC visits were associated with higher IPTp uptake [26, 
33]. The current findings further revealed the signifi-
cance of this factor, independent of the timing of the first 
ANC visit, suggesting the need for healthcare workers 
to encourage late ANC initiators to make frequent ANC 
visits. However, women who report late for ANC with 
complications, such as malaria infection, may make fre-
quent clinic visits and subsequently receive more SP as 
remedial treatment. In addition, the observed increased 
odds should be interpreted with caution because women 
who reported for ANC early in the third trimester may 
have completed the recommended IPTp dose, but those 
who reported late in the third trimester may not have.
Studies have reported age and marital status [23, 49], 
wealth [24, 30], education [23, 24, 30], and parity [23, 26, 
30] to be significant predictors for IPTp uptake. How-
ever, this study did not observe a significant association 
between socio-demographics and IPTp uptake. Instead, 
moderating effects of socio-demographics on the asso-
ciation between ANC attendance and IPTp uptake were 
found in the sub-group analyses. Specifically, the effect 
of adequate ANC visits on taking the recommended 
IPTp dose was significant among married women, those 
in the poor and middle wealth groups, and women aged 
≤ 34 years (p < 0.05). Notably, this relationship was signif-
icant at all levels of parity, with the highest odds observed 
for the multigravida group. In addition, the effect of 
desirable ANC timing on IPTp uptake was significant 
only among rural residents. Thus, tailor-made behav-
ioural-change messages on IPTp uptake for different vul-
nerable groups of women are required to ensure effective 
scale-up of IPTp uptake.
The use of a nationally representative sample could 
strengthen the generalization of these results to 
Malawian women; however, because information on 
IPTp uptake and ANC attendance relied on recall, recall 
bias may have occurred. Recall ability is considered to be 
associated with the vividness, meaningfulness and sig-
nificance of the event [50]. Recall may be better for less 
frequent and more significant events, such as the ones 
assessed in this study (IPTp uptake and ANC attend-
ance), however, recall bias might still have compromised 
the findings. The MDHS data used for the analysis have 
not been verified with participants’ recalled information 
Fig. 2 Sub‑group analysis for effect of socio‑demographics and 
ANC timing on recommended IPTp uptake. *p < 0.05. The timing of 
the first ANC visits was categorized into two levels: desirable timing 
(first and second trimester) and undesirable timing (third trimester) 
as reference. Results were adjusted for socio‑demographics (i.e., age, 
parity, marital status, education, wealth, occupation, and number of 
ANC visits, excluding the variable treated as the effect modifier)
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for either IPTp uptake or ANC attendance from the 
mothers on the ANC cards, which might have helped in 
reducing recall bias. Future studies should consider veri-
fying recalled information by using the mothers’ ANC 
or health cards. Limiting the participants to those with 
a live birth in the 2 years preceding the survey also may 
have helped to reduce recall bias. Crucial factors, such as 
previous malaria infection, infection of family members, 
and health facility-based factors (i.e., drug stock-outs and 
ANC health worker attitude), which might affect preg-
nant mothers’ intention to return to ANC and thus their 
IPTp uptake, could not be evaluated in this study. Finally, 
because this was a cross-sectional study, causality could 
not be inferred.
Conclusion
ANC attendance, namely the number of ANC visits and 
timing of the first visit, strongly influences IPTp uptake 
among Malawian women. The results demonstrated the 
independent association of these two ANC attendance 
assessments on IPTp uptake. In addition to frequent 
ANC visits, earlier ANC initiation should also be empha-
sized, which may simultaneously facilitate recommended 
IPTp uptake to appropriately protect pregnant women 
from the risk of malaria infection. The significant mod-
erating effects of socio-demographics can facilitate the 
identification and targeting of vulnerable groups to pro-
mote the recommended IPTp uptake rate in Malawi. Fur-
ther research is required to examine the effects of health 
facility-based factors on IPTp use and the effects of IPTp 
dose on birth outcomes. Qualitative studies interview-
ing both women and health personnel are also required 
for further elucidating barriers to recommended IPTp 
uptake.
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